Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Davis

Showing results (41-50 of 180) with videos related to

Pageof 18
Sort By:
Pharmacoeconomics|April 12, 2013
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying antirheumatic drugs: a NICE single technology appraisalJonathan Tosh, Rachel Archer, Sarah Davis, et al.
BMJ (Clinical Research Ed.)|November 12, 2017
Should cost effectiveness analyses for NICE always consider future unrelated medical costs?Pieter van Baal, Alec Morton, Werner Brouwer, et al.
Pharmacoeconomics|February 20, 2019
Correction to: Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case StudyMatthew Franklin, Sarah Davis, Michelle Horspool, et al.
The Clinical Journal of Pain|December 24, 2010
Beliefs about back pain: results of a population survey of working age adultsJulia Bowey-Morris, Sarah Davis, Gari Purcell-Jones, et al.
BMJ (Clinical Research Ed.)|May 28, 2021
Which is the best model to assess risk for venous thromboembolism in hospitalised patients?Daniel Horner, Steve Goodacre, Sarah Davis, et al.
Journal of Public Health Management and Practice : JPHMP|July 22, 2022
Training Public Health Professionals on Adaptive Challenges-An Innovative Approach Using Remote Learning ModalitiesElaine J Scallan Walter, Christine T Mousavi, Jill Elnicki, et al.
Palliative Medicine|February 13, 2019
Palliative care specialists in hospice and hospital/community teams predominantly use low doses of sedative medication at the end of life for patient comfort rather than sedation: Findings from focus groups and patient records for I-CAN-CAREBella Vivat, Lucy Bemand-Qureshi, Jane Harrington, et al.
Pharmacoeconomics|January 23, 2017
Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case StudyMatthew Franklin, Sarah Davis, Michelle Horspool, et al.
International Journal of Behavioral Medicine|October 25, 2022
Experiential Avoidance in Advanced Cancer: a Mixed-Methods Systematic ReviewSarah Davis, Marc Serfaty, Joe Low, et al.
Molecular Membrane Biology|August 7, 2009
Sodium translocation by the iminoglycinuria associated imino transporter (SLC6A20)Angelika Bröer, Sarojini Balkrishna, Gabor Kottra, et al.
Pageof 18

Showing results (41-50 of 180) with videos related to

Sort By:
Pageof 18
Pharmacoeconomics|April 12, 2013
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying antirheumatic drugs: a NICE single technology appraisalJonathan Tosh, Rachel Archer, Sarah Davis, et al.
BMJ (Clinical Research Ed.)|November 12, 2017
Should cost effectiveness analyses for NICE always consider future unrelated medical costs?Pieter van Baal, Alec Morton, Werner Brouwer, et al.
Pharmacoeconomics|February 20, 2019
Correction to: Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case StudyMatthew Franklin, Sarah Davis, Michelle Horspool, et al.
The Clinical Journal of Pain|December 24, 2010
Beliefs about back pain: results of a population survey of working age adultsJulia Bowey-Morris, Sarah Davis, Gari Purcell-Jones, et al.
BMJ (Clinical Research Ed.)|May 28, 2021
Which is the best model to assess risk for venous thromboembolism in hospitalised patients?Daniel Horner, Steve Goodacre, Sarah Davis, et al.
Journal of Public Health Management and Practice : JPHMP|July 22, 2022
Training Public Health Professionals on Adaptive Challenges-An Innovative Approach Using Remote Learning ModalitiesElaine J Scallan Walter, Christine T Mousavi, Jill Elnicki, et al.
Palliative Medicine|February 13, 2019
Palliative care specialists in hospice and hospital/community teams predominantly use low doses of sedative medication at the end of life for patient comfort rather than sedation: Findings from focus groups and patient records for I-CAN-CAREBella Vivat, Lucy Bemand-Qureshi, Jane Harrington, et al.
Pharmacoeconomics|January 23, 2017
Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case StudyMatthew Franklin, Sarah Davis, Michelle Horspool, et al.
International Journal of Behavioral Medicine|October 25, 2022
Experiential Avoidance in Advanced Cancer: a Mixed-Methods Systematic ReviewSarah Davis, Marc Serfaty, Joe Low, et al.
Molecular Membrane Biology|August 7, 2009
Sodium translocation by the iminoglycinuria associated imino transporter (SLC6A20)Angelika Bröer, Sarojini Balkrishna, Gabor Kottra, et al.
Pageof 18